Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00720239 · ClinicalTrials.gov registry record · Early Phase 1
Taliderm Dressing for Venous Ulcers
A Early Phase 1 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 50
- Enrollment target
NCT00720239 is a Early Phase 1 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 50 participants.
The verdict
NCT00720239, a Early Phase 1 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 50 participants
- Enrollment target
Study Summary
The study will test a new wound healing dressing called Taliderm® on leg ulcers caused by chronic venous insufficiency (CVI). Some people with CVI have poor vein circulation that causes ulcers to develop on the lower legs. This new dressing is hoped to help the ulcers heal more quickly. The study hypothesis is to determine whether the TalidermR Wound Dressing, a poly-N-acetyl glucosamine (pGlcNAc) derived membrane material expedites wound healing in humans with venous stasis ulcers.
Interventions
- OTHER Taliderm wound healing dressing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2008-02 |
| Est. Completion | 2010-08 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00720239
The ClinicalTrials.gov registry entry for NCT00720239 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Taliderm wound healing dressing is the first listed.
NCT00720239 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00720239 about?
NCT00720239 is a clinical study titled "Taliderm Dressing for Venous Ulcers". The study will test a new wound healing dressing called Taliderm® on leg ulcers caused by chronic venous insufficiency (CVI). Some people with CVI have poor vein circulation that causes ulcers to develop on the lower legs. This new dressing is hoped to help the ulcers heal more quickly. The study hy...
What is the current status of trial NCT00720239?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 50 participants. The study started on 2008-02. Estimated completion is 2010-08.
What interventions are being tested in trial NCT00720239?
The interventions under investigation include: Taliderm wound healing dressing (OTHER).
Who is sponsoring clinical trial NCT00720239?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.